MultiCell Technologies
MultiCell files patent on technologies to manipulate immune system to treat malignant tumors
Published in Cancer Law Weekly, October 28th, 2006
MultiCell does work in the science of modulating the human immune system with unique platform technologies, focusing on the development of breakthrough drugs to treat serious autoimmune diseases, including multiple sclerosis and type-1 diabetes, as well as influenza. Currently, the market for therapies that address these diseases is estimated at $8 billion worldwide.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2006-10-28)
More Articles from Cancer Law Weekly
- A-Viral
A-Viral's cancer study shows promising results - AMDL
AMDL closes Jade Pharmaceutical acquisition - British Columbia Cancer Agency, Canada
Abelson helper integration site gene functions in a variant of T cell lymphoma - Columbia University, U.S.
Reports on Columbia University, U.S. study findings provide new insights - Columbia University, U.S.
Studies from Columbia University, U.S., advance knowledge in breast cancer research - Royal Infirmary of Edinburgh, U.K.
ABCG2 overexpression in chronic myeloid leukemia CD34+ cells is inhibited by imatinib mesylate - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
